Daniela Tapia-Moreno

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity.

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity.

Journal: BMC medicine

Published: April 23, 2025

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Journal: iScience

Published: February 14, 2025

Development of a point-of-care test for the simultaneous detection of respiratory syncytial virus and IL-33 as a disease biomarker in children.

Development of a point-of-care test for the simultaneous detection of respiratory syncytial virus and IL-33 as a disease biomarker in children.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: February 05, 2025

T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2 Vaccine Using Multiparametric Flow Cytometry.

T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2 Vaccine Using Multiparametric Flow Cytometry.

Journal: European journal of immunology

Published: January 31, 2025

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Journal: Nature communications

Published: January 27, 2025

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.

Journal: EBioMedicine

Published: December 19, 2022

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Journal: mBio

Published: November 16, 2022

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

Journal: mBio

Published: August 10, 2022

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Journal: eLife

Published: June 29, 2022

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.

Journal: medRxiv : the preprint server for health sciences

Published: April 20, 2022

A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.

A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.

Journal: medRxiv : the preprint server for health sciences

Published: April 20, 2022

Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection.

Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection.

Journal: Antioxidants (Basel, Switzerland)

Published: March 07, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026